| abstract |
The invention relates to a nasal composition comprising: a saline base an active agent; an alkyl poly glucoside. According to one embodiment, the composition comprises from 0.01 to 1, preferably from 0.05 to 0.5 g, more preferably from 0. 1 to 0.3 g of alkyl poly glucoside per 100 ml of nasal spray composition. According to one embodiment, the alkyl poly glucoside is selected from the list consisting of decyl glucoside, coco glucoside, lauryl glucoside, hexyl glucoside, butyl glucoside, caprylyl/capryl glucoside and mixtures thereof. |